Interferon regulatory factor 1 (IRF-1) promotes intestinal group 3 innate lymphoid responses during Citrobacter rodentium infection

Nat Commun. 2022 Sep 29;13(1):5730. doi: 10.1038/s41467-022-33326-5.

Abstract

Group 3 innate lymphoid cells (ILC3s) are crucial mediators of immunity and epithelial barrier function during immune responses against extracellular bacteria. Here, we identify Interferon regulatory factor 1 (IRF-1), a transcription factor previously associated with type 1 immunity, as an essential regulator of intestinal ILC3 accumulation and effector cytokine production. We demonstrate that IRF-1 is upregulated in the context of infection with the enteropathogen Citrobacter rodentium and that its presence is central for anatomical containment and prevention of pathogen dissemination. We furthermore show that IRF-1 is required in order for intestinal ILC3s to produce large amounts of the protective effector cytokine IL-22 early in the course of infection. On a molecular level, our data indicate that IRF-1 controls ILC3 numbers and their activation by direct transcriptional regulation of the IL-12Rβ1 chain, thereby allowing ILCs to physiologically respond to IL-23 stimulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Citrobacter rodentium*
  • Cytokines
  • Enterobacteriaceae Infections*
  • Humans
  • Immunity, Innate
  • Interferon Regulatory Factor-1 / genetics
  • Interleukin-23
  • Lymphocytes

Substances

  • Cytokines
  • Interferon Regulatory Factor-1
  • Interleukin-23